MetaCap

Aardvark Therapeutics (AARD) vs TherapeuticsMD (TXMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

TherapeuticsMD (TXMD) has outperformed Aardvark Therapeutics (AARD) over the past year, losing 3.9% versus a loss of 90.2%. Aardvark Therapeutics is the larger company by market cap ($20.2 million vs $19.8 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AARD-90.15%TXMD-3.93%
+77%-11%-98%
Nov 21, 20251 yearNov 20, 2026
AARD-93.06%TXMD+66.02%
+166%+30%-105%
Feb 10, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AARD versus TXMD key metrics
MetricAARDTXMD
Share price$0.9226$1.71
Market cap$20.20M$19.79M
1-day change-7.74%-5.52%
YTD return-92.97%+4.91%
1-year return-90.15%-3.93%
5-year return—-94.10%
P/E ratio (TTM)—171.00
Forward P/E—4.89
EPS (TTM)$-3.33$0.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$0$3.02M
Revenue growth (YoY)—+71.61%
Net income (latest FY)$-57.59M$-569.00K
Operating margin—-145.27%
Net margin—-18.83%
52-week high$16.60$2.95
52-week low$0.90$1.43
Distance from 52-week high-94.44%-42.03%
Analyst consensusbuy—
Avg. price target upside+1104.21%—
Average volume643.53K24.50K
Shares outstanding21.89M11.57M
Employees281
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TXMD has outperformed AARD by 86.2 percentage points over the past year.

About Aardvark Therapeutics

AARD stock →

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc.

Health Care · Biotechnology: Pharmaceutical Preparations · 28 employees

About TherapeuticsMD

TXMD stock →

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

AARD vs TXMD FAQ

Which is bigger, Aardvark Therapeutics or TherapeuticsMD?

Aardvark Therapeutics (AARD) is larger, with a market capitalization of $20.20M compared with $19.79M for TherapeuticsMD (TXMD).

Which stock has performed better over the past year, AARD or TXMD?

TXMD returned -3.93% over the past 12 months, compared with -90.15% for AARD (price return, excluding dividends). Past performance does not predict future results.

Are Aardvark Therapeutics and TherapeuticsMD in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons